EMEA-002138-PIP01-17

  • Email
  • Help

Overview

Product details for -
Invented name-
Active substance

Carotuximab

Decision numberP/0383/2017
PIP numberEMEA-002138-PIP01-17
Pharmaceutical form(s)Concentrate for solution for infusion
Condition(s)/indication(s)

Treatment of soft tissue sarcoma

Route(s) of administrationIntravenous use
PIP applicant

TRACON Pharma Limited
Tel. +1 8585500780
E-mail: pbitar@traconpharma.com
sbenedict@traconpharma.com
ppathak@traconpharma.com

Decision typeP: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision